Idera Pharmaceuticals (NASDAQ: IDRA) today announced that Sudhir Agrawal, D. Phil., Chairman and Chief Executive Officer of Idera, will present a company overview at the Cowen and Company 32 nd Annual Healthcare Conference on March 7 th 2012, at 10:00 am EST in Boston, Massachusetts. A live audio webcast of the presentation will be available in the Investor section of Idera's website: www.iderapharma.com. An archived version will also be available on the Company's website after the event for a limited time. About Idera Pharmaceuticals, Inc. Idera Pharmaceuticals applies its proprietary Toll-like Receptor (TLR) drug discovery platform to create immunomodulatory drug candidates. The Company's TLR-targeted candidates are being developed to treat autoimmune and inflammatory diseases and cancer, and for use as vaccine adjuvants. Additionally, the Company is advancing its gene-silencing oligonucleotide (GSO) technology for the purpose of inhibiting the expression of disease-promoting genes. For more information, visit http://www.iderapharma.com.